ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

MRNA-1018

A development code. Also written as “mRNA-1018-H5”, “mRNA-1018 for H5N8” and “mRNA-1018 for H7N9”.

Its studies are mostly in Influenza, Human, led by Moderna.

Furthest: phase 3, since Mar 22, 20262 company-led studies, 1 open or runningNext primary completion: Jan 28, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Moderna21 open or runningphase 3since Mar 22, 2026Jul 25, 2023Jan 28, 2027phase 3 · NCT07496450

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 25, 2023First study: phase 2 study in Influenza, HumanFirst studyNCT05972174 · 1,504 enrolled · United States, United Kingdom
  2. Mar 22, 2026Phase 3 study in Influenza, HumanPhase 3 reachedNCT07496450 · 4,050 enrolled · United States, United Kingdom

Ahead

  1. Jan 28, 2027Primary completion: phase 3 study in Influenza, HumanNCT07496450

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07496450Influenza, Human · United States, United Kingdom3Active, not recruitingJan 28, 20274,050
NCT05972174Influenza, Human · United States, United Kingdom2CompletedJul 16, 20241,504

How it is read

Names in the registry

  • “mRNA-1018-H5”, 1 entry
  • “mRNA-1018 for H5N8”, 1 entry
  • “mRNA-1018 for H7N9”, 1 entry
  • “mRNA-1018 for H5 Only”, 1 entry
  • “mRNA-1018 for H7 Only”, 1 entry

Codes read as this program: MRNA1018.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.